Sanna Rydberg - Arcoma AB Chief Officer
ARCOMA Stock | SEK 10.45 0.20 1.88% |
Insider
Sanna Rydberg is Chief Officer of Arcoma AB
Age | 54 |
Phone | 46 4 70 70 69 00 |
Web | https://www.arcoma.se |
Arcoma AB Management Efficiency
The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0423 %, meaning that it generated $0.0423 on every $100 dollars invested by stockholders. Arcoma AB's management efficiency ratios could be used to measure how well Arcoma AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Thomas Joyce | Dignitana AB | N/A | |
Cameron OMara | Dignitana AB | 44 | |
Christian Lindgren | Dignitana AB | 49 | |
Maria Edholm | Genovis AB | N/A | |
BA BA | Genovis AB | N/A | |
Susanne Ahlberg | Genovis AB | 66 | |
Sofia Aru | Avensia publ AB | N/A | |
Magnus Langberg | Genovis AB | 52 | |
Patrik Sundquist | Avensia publ AB | 36 | |
Anette Cronstroem | Dignitana AB | N/A | |
Jane Wall | Dignitana AB | N/A | |
Fredrik Andre | Avensia publ AB | 50 | |
Johan Johansson | Dignitana AB | N/A | |
Gunilla Savring | aXichem AB | 61 | |
Erik Lager | aXichem AB | 48 | |
John Anderson | Stille AB | 48 | |
Jrgen Bertilsson | Avensia publ AB | 51 | |
Lisa Logren | Avensia publ AB | N/A | |
Rikke Rytter | Genovis AB | 56 | |
Hanna Wilkman | Stille AB | 56 | |
Lucas Altepost | aXichem AB | 56 |
Management Performance
Return On Equity | 0.0423 | |||
Return On Asset | 0.0218 |
Arcoma AB Leadership Team
Elected by the shareholders, the Arcoma AB's board of directors comprises two types of representatives: Arcoma AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arcoma. The board's role is to monitor Arcoma AB's management team and ensure that shareholders' interests are well served. Arcoma AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arcoma AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frida Robbe, Marketing Mang | ||
Sanna Rydberg, Chief Officer | ||
Johan Dahlberg, Chief Officer | ||
Peter Reinli, Pres IMIX ADR Ltd | ||
Nicklas Johansson, Operations Manager |
Arcoma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arcoma AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0423 | |||
Return On Asset | 0.0218 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.02 % | |||
Current Valuation | 112.49 M | |||
Shares Outstanding | 13.05 M | |||
Shares Owned By Insiders | 46.73 % | |||
Shares Owned By Institutions | 25.01 % | |||
Price To Earning | 70.28 X | |||
Price To Book | 2.26 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Arcoma Stock
Arcoma AB financial ratios help investors to determine whether Arcoma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcoma with respect to the benefits of owning Arcoma AB security.